IGF1 and early-onset autosomal dominant Alzheimer disease: At the signal transduction level, post-mortem analysis of brains from patients with Alzheimer’s disease reveals perturbed signaling downstream of the insulin receptor, including reduced insulin and IGF-1 binding to their receptors and impaired PI3K/Akt signaling44–47.